P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

Detalles Bibliográficos
Autores principales: Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012127/
http://dx.doi.org/10.1097/01.HS9.0000829640.69738.dc

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012127/
http://dx.doi.org/10.1097/01.HS9.0000829640.69738.dc

Ejemplares similares